Evoq Remedies Ltd

Company Profile

Evoq Remedies Ltd had its IPO on under the ticker symbol EVOQ.

The company operates in the Healthcare sector and Pharmaceuticals industry. Evoq Remedies Ltd has a staff strength of 0 employees.

Stock update

Shares of Evoq Remedies Ltd opened at ₹15.75 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹15.7 - ₹15.75, and closed at ₹15.7.

This is a +0.13% increase from the previous day's closing price.

A total volume of 16,000 shares were traded at the close of the day’s session.

In the last one week, shares of Evoq Remedies Ltd have increased by +4.39%.

Evoq Remedies Ltd's Key Ratios

Evoq Remedies Ltd has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Evoq Remedies Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Evoq Remedies Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Evoq Remedies Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q3.6666666666667, Evoq Remedies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Evoq Remedies Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Evoq Remedies Ltd’s profitability.

Evoq Remedies Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Evoq Remedies Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Evoq Remedies Ltd ended 1970 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

Evoq Remedies Ltd ended 1970 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Evoq Remedies Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 1970, Evoq Remedies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Evoq Remedies Ltd paid ₹0 in dividends in 1970.

Other key metrics

Current Trading Price

₹15.7

52-Week High

₹24.49

52-Week Low

₹10.91

Analyst Target Price

₹

Evoq Remedies Ltd stock is currently trading at ₹15.7 per share. It touched a 52-week high of ₹24.49 and a 52-week low of ₹24.49. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹14.82 and 200-day moving average was ₹14.8 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.